IXC 1.43% 7.1¢ invex therapeutics ltd

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-12

  1. 392 Posts.
    lightbulb Created with Sketch. 47
    They still have a few months before the trial begins. By the way, trials can run in a COVID-impacted environment (it takes a lot to stop medical research from happening), but the study group will just need to submit a COVID risk management plan to the Human Research Ethics Committee to explain how they can work around potential interruptions to data collection - e.g., they can perform some parts of the trial at home (e.g., medical history interview over zoom or phone etc).

    The research team, led by Prof. Sinclair, is highly experienced and will have considered the effects of COVID in their plan and timeline.


 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.1¢
Change
0.001(1.43%)
Mkt cap ! $5.335M
Open High Low Value Volume
7.1¢ 7.3¢ 7.1¢ $2.546K 35.86K

Buyers (Bids)

No. Vol. Price($)
1 14158 7.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 5000 1
View Market Depth
Last trade - 14.37pm 31/07/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.